J&J's 'must-win launch' Icotyde nabs 18,000 prescriptions in first full quarter

J&J's plaque psoriasis drug Icotyde drew 18,000+ prescriptions for 11,000 patients in its first full quarter of sales.

Raccontata daendpoints.news